Divergent effect of cobalt and beryllium salts on the fate of peripheral blood monocytes and T lymphocytes

Toxicological Sciences

Volumn 119, Issue 2, 2011, Pages 257-269

  Paladini, Fabiana ^a   Cocco, Elisa ^a   Potolicchio, Ilaria ^b   Fazekasova, Henrieta ^c   Lombardi, Giovanna ^c   Fiorillo, Maria Teresa ^a   Sorrentino, Rosa ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Inflammasome; Inflammation; Lung; Lymphocytes; Metal salts; Monocytes

Indexed keywords

BERYLLIUM; CD16 ANTIGEN; CD83 ANTIGEN; COBALT CHLORIDE; CYCLIN DEPENDENT KINASE INHIBITOR 1; GAMMA INTERFERON; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; PROTEIN P53;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; MACROPHAGE; MONOCYTE; OCCUPATIONAL EXPOSURE; PERIPHERAL LYMPHOCYTE; PROTEIN EXPRESSION; PROTEIN INDUCTION; RISK FACTOR; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 78751680984     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfq328     Document Type: Article

References (40)

1. Abbas, T., and Dutta, A. (2009). p21 in cancer: intricate networks and multiple activities. Nat. Rev. Cancer 9, 400-414.
2. Asada, M., Yamada, T., Ichijo, H., Delia, D., Miyazono, K., Fukumuro, K., and Mizutani, S. (1999). Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J. 18, 1223-1234.
3. Caicedo, M. S., Desai, R., McAllister, K., Reddy, A., Jacobs, J. J., Hallab, N., and J. (2009). Soluble and particulate Co-Cr-Mo alloy implant metals activate the inflammasome danger signaling pathway in human macrophages: a novel mechanism for implant debris reactivity. J Orthop. Res. 27, 847-854.
4. Cassel, S. L., Eisenbarth, S. C., Iyer, S. S., Sadler, J. J., Colegio, O. R., Tephly, L. A., Carter, A. B., Rothman, P. B., Flavell, R. A., and Sutterwala, F. S. (2008). The Nalp3 inflammasome is essential for the development of silicosis. Proc. Natl. Acad. Sci. U.S.A. 105, 9035-9040.
5. Chiappino, G. (1994). Hard metal disease: clinical aspects. Sci. Total Environ. 150, 65-68.
6. De Boeck, M., Lison, D., and Kirsch-Volders, M. (1998). Evaluation of the in vivo direct and indirect genotoxic effects of cobalt compounds using the alkaline comet assay. Influence of interdonor and interexperimental variability. Carcinogenesis 19, 2021-2029.
7. Demedts, M., Gheysens, B., Nagels, J., Verbeken, E., Lauweryns, J., and Van Den Eeckhout, A. (1984). Cobalt lung in diamond polishers. Am. Rev. Respir. Dis. 130, 130-135.
8. Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., and Tschopp, J. (2008). Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320, 674-677.
9. Dotto, G. P. (2000). p21(WAF1/Cip1): more than a break to the cell cycle? Biochim. Biophys. Acta. 1471, M43-M56.
10. + T cells underlines diseasesusceptibility HLA-DP alleles in chronic beryllium disease. Proc. Natl. Acad. Sci. U.S.A. 97, 12717-12722.
11. Freiman, D. G., and Hardy, H. L. (1970). Beryllium disease: the relation of pulmonary pathology to clinical course and prognosis based on study of 130 cases from the U.S. beryllium case registry. Hum. Pathol. 1, 25-28.
12. Kasprzak, K. S. (2002). Oxidative DNA and protein damage in metal induced toxicity and carcinogenesis. Free Radic. Biol. Med. 32, 958-967.
13. Kaufman, A. M., Alabre, C. I., Rubash, H. E., and Shanbhag, A. S. (2008). Human macrophage response to UHMWPE, TiAlV, CoCr, and alumina particles: analysis of multiple cytokines using protein arrays. J. Biomed. Mater. Res.A. 84, 464-474.
14. Lamkanfi, M., Kanneganti, T. D., Franchi, L., and Nunez, G. (2007). Caspase-1 inflammasomes in infection and inflammation. J. Leukoc. Biol. 82, 220-225.
15. Lison, D. (1996). Human toxicity of cobalt-containing dust and experimental studies on mechanism of interstitial lung disease (hard metal disease). Crit. Rev. Toxicol. 26, 585-616.
16. Lombardi, G., Germain, C., Uren, J., Fiorillo, M. T., Du Bois, R. M., Jones-Williams, W., Saltini, C., Sorrentino, R., and Lechler, R. (2001). HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease. J. Immunol. 166, 3549-3555.
17. Lue, H., Kleemann, R., Calandra, T., Roger, T., and Berhagen, J. (2002). Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect. 4, 449-460.
18. Mariathasan, S., and Monack, D. M. (2007). Inflammasome adaptors and sensor: intracellular regulators of infection and inflammation. Nat. Rev. Immunol. 7, 31-40.
19. Matas, D., Milyavsky, M., Shats, I., Nissim, L., Goldfinger, N., and Rotter, V. (2004). p53 is a regulator of macrophage differentiation. Cell Death Differ. 11, 458-467.
20. McCanlies, E. C., Ensey, J. S., Schuler, C. R., Kreiss, K., and Weston, A. (2004). The association between HLA-DPB1 Glu 69 and chronic beryllium disease and beryllium sensitisation. Am. J. Ind. Med. 46, 95-103.
21. Mudipalli, A., Li, Z., Hromchak, R., and Bloch, A. (2001). NF-kappaB (p65/RelA) as a regulator of TNFalpha-mediated ML-1 cell differentiation. Leukemia 15, 808-813.
22. Navrátilová, J., Horváth, V., Kozubík, A., Lojek, A., Lipsick, J., and Smarda, J. (2007). p53 arrests growth and induces differentiation of v-Myb-transformed monoblasts. Differentiation 75, 592-604.
23. Nemery, B., Blast, A., Beher, J., Borm, P. J., Bourke, S. J., and Camus, P. H. (2001a). Intertial lung disease induced by exogenous agents: factors governing susceptibility. Eur. Respir. J. 18, 30s-42s.
24. Nemery, B., Verbeken, E. K., and Demets, M. (2001b). Giant cell interstitial pneumonia (hard metal lung disease, cobalt lung). Semin. Respir. Crit. Care Med. 22, 435-447.
25. Netea, M. G., Nold-Petry, C. A., Nold, M. F., Joosten, L. A., Opitz, B., van der Meer, J. H. M., van de Veerdonk, F. L., Ferwerda, G., Heinhuis, B., et al. (2009). Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 113, 2324-2335.
26. Novak, D. E., Tian, B., Jamaluddin, M., Boldogh, I., Vergara, L. A., Choudhary, S., and Brasier, A. R. (2008). RelA Ser276 phosphorylation is required for activation of a subset of NF-kappaB-dependent genes by recruiting cyclin-dependent kinase 9/cyclin T1 complexes. Mol. Cell. Biol. 28, 3623-3638.
27. Oda, T., Hirota, K., Nishi, K., Takabuchi, S., Oda, S., and Yamada, H. (2006). Activation of hypoxia-inducible factor 1 during macrophage differentiation. Am. J. Physiol. Cell Physiol. 291, C104-C113.
28. Ohori, N. P., Sciurba, F. C., Owens, G. R., Hodgson, M. J., and Yousem, S. A. (1989). Giant cell interstitial pneumonia and hard-metal pneumoconiosis: a clinico-pathologic study of four cases and review of literature. Am. J. Surg. Pathol. 13, 581-587.
29. Okazaki, T., Sakon, S., Sasazuki, H., Doi, T., Yagita, H., Okumura, K., and Nakano, H. (2003). Phosphorylation of serina 276 is essential for p65 NFkappaB subunit-dependent cellular responses. Biochem. Biophys. Res. Commun. 300, 807-812.
30. Pennington, K. N., Taylor, J. A., Bren, G. D., and Paya, C. V. (2001). IkB kinase-dependent chronic activation of NF-kB is necessary for p21 WAF17Cip inhibition of differentiation-induced apoptosis of monocytes. Mol. Cell. Biol. 21, 1930-1941.
31. Ping, B., He, X., Xia, W., Lee, D. F., Wei, Y., Yu, D., Mills, G., Shi, D., and Hung, M. C. (2006). Cytoplasmic expression of p21CIP1/WAF1 is correlated with IKKbeta overexpression in human breast cancers. Int. J. Oncol. 29, 1103-1110.
32. Potolicchio, I., Mosconi, G., Forni, A., Nemery, B., Seghizzi, P., and Sorrentino, R. (1997). Susceptibility to hard metal lung disease is strongly associated with the presence of glutamate 69 in HLA-DPβ chain. Eur. J. Immunol. 27, 2741-2743.
33. Rengasamy, A., Kanmineni, C., Jones, J. A., and Fedon, J. S. (1999). Effects of hard metal on nitric oxide pathways and airway reactivity to methacoline in rat lungs. Toxicol. Appl. Pharmacol. 157, 178-191.
34. Richeldi, L., Sorrentino, R., and Saltini, C. (1993). HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science 262, 242-244.
35. Rivolta, G., Nicoli, E., Ferretti, G., and Tomasini, M. (1994). Hard metal lung disorders: analysis of a group of exposed workers. Sci. Total Environ. 150, 161-165.
36. Saltini, C., Winestock, M., Kirby, P., Pinkston, P., and Crystal, R. G. (1989). Maintenance of alveolitis in patients with chronic beryllium disease by beryllium specific helper T cells. N. Engl. J. Med. 320, 1103-1109.
37. Sandau, K. B., Fandrey, J., and Brune, B. (2000). Accumulation of HIF-1a under the influence of nitric oxide. Immunobiology 97, 1009-1015.
38. Sawyer, R. T., Dobis, D. R., Goldstein, M., Velsor, L., Maier, L. A., Fontenot, A. P., Silveira, L., Newman, L. S., and Day, B. J. (2005). Beryllium-stimulated reactive oxygen species and macrophage apoptosis. Free Radic. Biol. Med. 38, 928-937.
39. Won, G. A., Kanekal, M., Simon, M. C., Maltepe, E., Blagosklonny, M. V., and Neckers, L. M. (1998). Stabilization of wild-type p53 by hypoxiainducible factor 1α. Nature 392, 405-408.
40. Zhang, W., Petrovic, J. M., Callaghan, D., Jones, A., Cui, H., Howlett, C., and Stanimirovic, D. (2006). Evidence that hypoxia-inducible factor-1 (HIF-1) mediates transcriptional activation of interleukin-1beta (IL-1beta) in astrocyte cultures. J. Neuroimmunol. 174, 63-73.